Study of LJP 394 (Abetimus Sodium) in Lupus Patients

Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone

NCT00119678 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

NCT04451772 ·Status: COMPLETED ·Phase: PHASE2

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT05843643 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus

NCT03451422 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

NCT02446899 ·Status: COMPLETED ·Phase: PHASE3

A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects

NCT05203692 ·Status: COMPLETED ·Phase: PHASE1

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

NCT05268289 ·Status: RECRUITING ·Phase: PHASE2

Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus

NCT05966480 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

NCT02446912 ·Status: COMPLETED ·Phase: PHASE3

Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches

NCT02270957 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

NCT05039619 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

NCT00430677 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

NCT01714817 ·Status: TERMINATED ·Phase: PHASE3

Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)

NCT00299819 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus

NCT02920424 ·Status: WITHDRAWN ·Phase: PHASE1

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

NCT06411249 ·Status: RECRUITING ·Phase: PHASE4

An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184

NCT01777256 ·Status: TERMINATED ·Phase: PHASE2

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE Participants

NCT06625671 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

NCT06013995 ·Status: RECRUITING ·Phase: PHASE1

A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus Erythematosus

NCT02609789 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

NCT03978520 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

NCT04186871 ·Status: COMPLETED ·Phase: PHASE2

An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis

NCT03385564 ·Status: COMPLETED ·Phase: PHASE2

A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects

NCT01894360 ·Status: COMPLETED ·Phase: PHASE1

Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE)

NCT00997100 ·Status: COMPLETED ·Phase: PHASE2